Home » Without Label » Tatva Chintan : Tatva Chintan shares make strong debut, list at 95% ... - It ended the session at rs 2,310.25, with a gain of 113.3 per cent.
Tatva Chintan : Tatva Chintan shares make strong debut, list at 95% ... - It ended the session at rs 2,310.25, with a gain of 113.3 per cent.
Tatva Chintan : Tatva Chintan shares make strong debut, list at 95% ... - It ended the session at rs 2,310.25, with a gain of 113.3 per cent.. Tatva chintan shares in the grey market are commanding a strong premium. On thursday, the market could remain in the trading range of 15800 and 15600. Tatva chintan pharma chem pvt ltd, is one of the fastest growing company in manufacturing of specialty chemicals with world class facilities at ankleshwar, dahej sez & r&d center at vadodara. Tatva chintan pharma made a stellar debut on the stock markets on thursday. The minimum order quantity is 13 shares.
The basis of allotment for shares of tatva chintan is likely to be finalised by monday, july 26. The specialty chemical maker's stock listed at rs 2,111.85 apiece, a premium of 95% to its issue price. As allotment date is fast approaching, bidders are eagerly waiting for the finalisation of share allotment process as market observers are expecting huge listing gain from the. It has a strong customer relationship with marquee players like merck, bayer ag, asian paints ltd. The gmp for tatva chintan shares have been constantly rising.
Tatva Chintan IPO allotment: Check GMP and application ... from mycapitalmarket.com Most brokerages recommend 'subscribe' for tatva chintan pharma ipo on the back of robust financials, strong growth potential, diversification, potential play on green chemistry, discounted valuation compared to its peers and niche global placement. After record subscription of over 180 times of the original offer, tatva chintan pharma ipo (initial public offer) became the second most subscribed ipo in 2021 after mtar technologies. It will be the fourth public issue to hit the markets this month. Tatva chintan pharma chem pvt ltd, is one of the fastest growing company in manufacturing of specialty chemicals with world class facilities at ankleshwar, dahej sez & r&d center at vadodara. Tatva chintan pharma chem is a chemical manufacturing company that manufactures structure directing agents (sdas), phase transfer catalyst (ptcs), pharmaceutical and agrochemical intermediates, and other specialty chemicals. The shares of the company are expected to list on thursday, july 29. As per the groww, zerodha & media reports, the tatva chintan allotment status will be available around 26, july 2021. Shares of tatva chintan pharma chem more than doubled during their stock market debut on thursday.
Tatva chintan is a specialty chemical manufacturing company.
Tatva chintan shares in the grey market are commanding a strong premium. About tatva chintan pharma chem limited. The investors can check their application status by visiting registrar website i.e linkintime.co.in. The ipo opens on jul 16, 2021, and closes on jul 20, 2021. Let us learn more about the company and its ipo. Tatva chintan pharma chem is the largest and only commercial manufacturer of sdas for zeolites which is used as a catalyst in several important chemical reactions, in india. With presence in us, europe & japan market and an impeccable track record of more than 24 years. Bumper bidding for stocks, soaring premium at the grey market signal that the pharma stock. The stock got listed at rs 2,111, with a gain of 95 per cent over the issue price of rs 903 per share. Most brokerages recommend 'subscribe' for tatva chintan pharma ipo on the back of robust financials, strong growth potential, diversification, potential play on green chemistry, discounted valuation compared to its peers and niche global placement. As allotment date is fast approaching, bidders are eagerly waiting for the finalisation of share allotment process as market observers are expecting huge listing gain from the. The stocks got listed with a massive premium of 95 per cent against the issue price of ₹1,083. Tatva chintan pharma chem limited is entering in the capital market with an ipo of . equity shares of rs 10 aggregating up to rs 450.00 crore.
Tatva chintan pharma chem ltd hit the market floor with a stellar initial public offering (ipo) of rs 500 crore on july 16. Tatva chintan pharma ipo opens on jul 16, 2021 monday, july 12, 2021 6:24:49 am. Tatva chintan ipo application date was closed on 20th july 2021. After record subscription of over 180 times of the original offer, tatva chintan pharma ipo (initial public offer) became the second most subscribed ipo in 2021 after mtar technologies. Tatva chintan pharma ipo allotment date 2021.
IPO de Tatva Chintan Pharma Chem Ltd : Pour ceux qui ... from decodethenewspodcast.com About tatva chintan pharma chem limited. Shares of tatva chintan pharma chem more than doubled during their stock market debut on thursday. Tatva chintan pharma shares will list on the bourses tomorrow. Companies also planning to expand their r&d facility, which is the key to growth for the company. Tatva chintan is the largest and only commercial manufacturer of sdas for zeolites (used as a catalyst in several important chemical reactions) in india and enjoys the second largest position. It will be the fourth public issue to hit the markets this month. The basis of allotment for shares of tatva chintan is likely to be finalised by monday, july 26. Tatva chintan pharma ipo allotment status 2021 for ipo size of rs 500 crore will be announced on 26 july 2021.
Tatva chintan pharma chem limited is all set for a stellar market debut on thursday.
The stocks got listed with a massive premium of 95 per cent against the issue price of ₹1,083. Alternatively, check bseindia.com page to check youe status. Tatva chintan pharma chem is a chemical manufacturing company that manufactures structure directing agents (sdas), phase transfer catalyst (ptcs), pharmaceutical and agrochemical intermediates, and other specialty chemicals. It is engaged in manufacturing a variety of catalysts, disinfectants, agro and pharmaceutical intermediates, among other products. It will be the fourth public issue to hit the markets this month. Tatva chintan pharma chem limited is entering in the capital market with an ipo of . equity shares of rs 10 aggregating up to rs 450.00 crore. As allotment date is fast approaching, bidders are eagerly waiting for the finalisation of share allotment process as market observers are expecting huge listing gain from the. The ipo was allotted at rs 1083 per equity share. Globally, it is the second largest manufacturer of sdas. The ipo stands as a strong pillar as its popularity with investors was evident due to the subscriptions of around 180.36 times by the time it closed. The basis of allotment for shares of tatva chintan is likely to be finalised by monday, july 26. Tatva chintan pharma chem limited is all set for a stellar market debut on thursday. The r&d team has helped tatva chintan grow from 72 products in fy 11 to 138 products in fy 20.
The specialty chemical maker's stock listed at rs 2,111.85 apiece, a premium of 95% to its issue price. The specialty chemical maker's rs 500 crore ipo, which was open between july 18 and 20, had received a massive interest from the. The stock got listed at rs 2,111, with a gain of 95 per cent over the issue price of rs 903 per share. Tatva chintan is one of the major players in the specialty chemicals segment with its broad range of products. Alternatively, check bseindia.com page to check youe status.
Tatva Chintan Pharma IPO Share Allotment, Listing Date ... from i0.wp.com Tatva chintan pharma chem is a chemical manufacturing company that manufactures structure directing agents (sdas), phase transfer catalyst (ptcs), pharmaceutical and agrochemical intermediates, and other specialty chemicals. The shares of the company are expected to list on thursday, july 29. The ipo opens on jul 16, 2021, and closes on jul 20, 2021. Tatva chintan shares in the grey market are commanding a strong premium. Tatva chintan pharma chem pvt ltd, is one of the fastest growing company in manufacturing of specialty chemicals with world class facilities at ankleshwar, dahej sez & r&d center at vadodara. Most brokerages recommend 'subscribe' for tatva chintan pharma ipo on the back of robust financials, strong growth potential, diversification, potential play on green chemistry, discounted valuation compared to its peers and niche global placement. Shares of tatva chintan pharma chem more than doubled during their stock market debut on thursday. The gmp of tatva chintan share is currently at rs.
The ipo was allotted at rs 1083 per equity share.
The company takes 6 working days to finish the finalization of shares. Also, tatva chintan pharma chem ip shares will make their stock market debut. Tatva chintan is one of the major players in the specialty chemicals segment with its broad range of products. The specialty chemical maker's stock listed at rs 2,111.85 apiece, a premium of 95% to its issue price. The shares of the company are expected to list on thursday, july 29. As per the groww, zerodha & media reports, the tatva chintan allotment status will be available around 26, july 2021. The investors can check their application status by visiting registrar website i.e linkintime.co.in. The ipo stands as a strong pillar as its popularity with investors was evident due to the subscriptions of around 180.36 times by the time it closed. The minimum order quantity is 13 shares. As allotment date is fast approaching, bidders are eagerly waiting for the finalisation of share allotment process as market observers are expecting huge listing gain from the. The stocks got listed with a massive premium of 95 per cent against the issue price of ₹1,083. Shares of tatva chintan pharma chem more than doubled during their stock market debut on thursday. The specialty chemical maker's rs 500 crore ipo, which was open between july 18 and 20, had received a massive interest from the.
